The lncRNA PAR5 has been recently characterized by our group as a tumor suppressor lncRNA acting through the interaction and inhibition of the Enhancer Of Zeste 2 (EZH2) protein in anaplastic thyroid cancer [17]. This evidence concerns the gene EZH2 and neoplasm.